BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21649457)

  • 1. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
    Hsu CH; Liao YL; Lin SC; Tsai TH; Huang CJ; Chou P
    Altern Med Rev; 2011 Jun; 16(2):157-63. PubMed ID: 21649457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.
    Dostal AM; Samavat H; Espejo L; Arikawa AY; Stendell-Hollis NR; Kurzer MS
    J Nutr; 2016 Jan; 146(1):38-45. PubMed ID: 26581683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial.
    Lu PH; Hsu CH
    Complement Ther Med; 2016 Apr; 25():159-63. PubMed ID: 27062963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial.
    Hsu CH; Tsai TH; Kao YH; Hwang KC; Tseng TY; Chou P
    Clin Nutr; 2008 Jun; 27(3):363-70. PubMed ID: 18468736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.
    Samavat H; Newman AR; Wang R; Yuan JM; Wu AH; Kurzer MS
    Am J Clin Nutr; 2016 Dec; 104(6):1671-1682. PubMed ID: 27806972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.
    Dostal AM; Arikawa A; Espejo L; Kurzer MS
    J Nutr; 2016 Feb; 146(2):256-64. PubMed ID: 26701796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial.
    Chen IJ; Liu CY; Chiu JP; Hsu CH
    Clin Nutr; 2016 Jun; 35(3):592-9. PubMed ID: 26093535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women.
    Dostal AM; Arikawa A; Espejo L; Bedell S; Kurzer MS; Stendell-Hollis NR
    J Hum Nutr Diet; 2017 Apr; 30(2):166-176. PubMed ID: 27600055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial.
    Huang LH; Liu CY; Wang LY; Huang CJ; Hsu CH
    BMC Complement Altern Med; 2018 Nov; 18(1):294. PubMed ID: 30400924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.
    Samavat H; Wu AH; Ursin G; Torkelson CJ; Wang R; Yu MC; Yee D; Kurzer MS; Yuan JM
    J Nutr; 2019 Apr; 149(4):619-627. PubMed ID: 30926986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.
    Samavat H; Ursin G; Emory TH; Lee E; Wang R; Torkelson CJ; Dostal AM; Swenson K; Le CT; Yang CS; Yu MC; Yee D; Wu AH; Yuan JM; Kurzer MS
    Cancer Prev Res (Phila); 2017 Dec; 10(12):710-718. PubMed ID: 28904061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.
    Bogdanski P; Suliburska J; Szulinska M; Stepien M; Pupek-Musialik D; Jablecka A
    Nutr Res; 2012 Jun; 32(6):421-7. PubMed ID: 22749178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
    Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
    Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome.
    Zeng M; Hodges JK; Pokala A; Khalafi M; Sasaki GY; Pierson J; Cao S; Brock G; Yu Z; Zhu J; Vodovotz Y; Bruno RS
    Nutr Res; 2024 Apr; 124():94-110. PubMed ID: 38430822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
    Brown AL; Lane J; Coverly J; Stocks J; Jackson S; Stephen A; Bluck L; Coward A; Hendrickx H
    Br J Nutr; 2009 Mar; 101(6):886-94. PubMed ID: 18710606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
    Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I
    Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.